🔥 Hot off the library cart! 🔥 Librarians, it’s your time to shine! Cast a vote for your favorite tote and help us pick this year’s #ToteVote design! Will it be open access, journal pride, or a simple heart for books? 👜✅ Vote & help choose the winner: https://lnkd.in/eQN5gDAJ Voting will be open through May 31! #totevote2024 #LibrariansUnite
Mary Ann Liebert, Inc.
Book and Periodical Publishing
New Rochelle, New York 7,895 followers
Publications at the Forefront of Science, Technology, Engineering, and Medicine. (STEM)
About us
Mary Ann Liebert, Inc. is a leading independent publisher known worldwide for its prescience and establishment of authoritative peer-reviewed journals, books, and trade publications in cutting-edge fields such as biotechnology, biomedical research, clinical medicine and surgery, public health, technology and engineering, law, environmental policy, and other specialized disciplines. The company publishes over 90 peer-reviewed journals, leading trade magazines, and specialized newsletters, in addition to society membership management and conferences. Mary Ann Liebert Inc. was founded in 1980 and is based in New Rochelle, New York.
- Website
- http://www.liebertpub.com
External link for Mary Ann Liebert, Inc.
- Industry
- Book and Periodical Publishing
- Company size
- 51-200 employees
- Headquarters
- New Rochelle, New York
- Type
- Privately Held
- Founded
- 1980
- Specialties
- STM Publishing & Peer Reviewed Journals, Biomedical research & life sciences, Clinical medicine and surgery, Alternative & complementary medicine, Election, Environmental & Other Legal Issues, Philanthropy & Planned Giving, and Environmental Science & Sustainability
Locations
- Primary
140 Huguenot Street
3rd Floor
New Rochelle, New York 10801-5215, US
Employees at Mary Ann Liebert, Inc.
Updates
-
Congratulations to David B. Nash, MD, MBA, the Editor-in-Chief of our renowned journal Population Health Management, for this well deserved honor!
We’re excited to release our third annual Top 50 Value-Based Care Thinkers list, which recognizes healthcare providers, policy makers, academics, and thinkers across disciplines who are leading the healthcare system’s transition to value-based care. The leaders in this report are from 50 different organizations, representing a broad cross-section of US healthcare and offering diverse perspectives on the challenges in the healthcare system and the opportunities presented by the transition from volume to value. Along with quotes from 30 of this year’s honorees, Pearl Health’s #Top50VBC report identifies and explains major themes, news, and trends driving innovation in healthcare in 2024 and beyond. Read more insights in Pearl Health’s Top 50 Value-Based Care Thinkers of 2024: pearlhealth.com/top50vbc Congratulations to all 2024 honorees! George M. Aloth Julia Andrieni, MD Andy Bindman Jonathan Blum Adam Boehler Michael Carson Michael Chernew Frank Cheung Aneesh Chopra Mark Cuban Brent Davis Karen DeSalvo Isaac Edrah Katila Farley, RN, CMOM Olaoluwa “Láolú” Fayanju, MD MSc, FAAFP Elliott Fisher Lee Fleisher Liz F. Susannah Fox Eric Gallagher Faris Ghawi Ryan A. Grant, MD, MS, MBA, FAANS Lacy Heiberger Sachin H. Jain, MD, MBA S. Claiborne "Clay" Johnston Sarah Kachur PharmD MBA BCACP Curtis Lane Leonard Lindenmuth DHA Blake Madden James McDonald MD MPH Vince Micucci Sashi Moodley, MD, MBA Matthew Moore Jessica Morgan, MD David B. Nash, MD, MBA Kevin O'Leary Dan O'Neill Yubin Park, PhD Mitch Perry Michael Porter
-
📰 New Research on Gender-Affirming Care in Pediatrics! 🩺 A study in Telemedicine and e-Health shows consultative support boosts pediatric primary care providers' comfort in offering gender-affirming care, improving outcomes for gender-diverse adolescents. Training for PPCPs is crucial. 🔗Access the full article: https://ow.ly/KhhP50RQL5m #GenderAffirmingCare #Telemedicine
-
Register now for our half-day virtual summit: THE STATE OF CRISPR AND GENE EDITING! 🗓️ June 5th, 2024 🕒 4.5-hour FREE event 📍 Hosted by Genetic Engineering & Biotechnology News 🎤 Sponsored by Aldevron and seqWell ✨Join industry experts and discover the latest in CRISPR and gene editing. Register for free: https://ow.ly/rNIn50RNWAa 🤝 Share with colleagues! #StateofCRISPR2024 #CRISPR #GeneEditing #Biotechnology #GeneticEngineering
-
🎉 Librarians, your expertise is in demand ! 📚 Which slogan speaks to your librarian heart? Vote now for your favorite design in the #totevote2024 campaign. 🗳️ Vote here: https://lnkd.in/eQN5gDAJ #Librarians #ToteVote2024
-
Mary Ann Liebert, Inc., is delighted to announce that Steven Laureys MD, PhD, MAE, FEAN has been appointed the new Editor-in-Chief of the journal Brain Connectivity. Brain Connectivity welcomes groundbreaking research on all aspects of systems and network-level brain connectivity and brain mapping research. Join our journal community and submit your manuscript for consideration today: https://lnkd.in/ey4immDw
-
RICHARD WOLF PODCAST #67 AVAILABLE NOW! The current status of aquablation of the prostate. Amongst the many options for treatment of enlarged prostate, aquablation is growing in popularity. Dr. Netsch offers his expertise in discussing this technology. LISTEN: https://ow.ly/PIK550RCf8N
-
DON'T MISS OUT! Streamlining Cell and Gene Therapy Scalability: Progress Towards a Gold Standard In this May 13th roundtable webinar, our expert panelists from across the CGT space will discuss a concept-to-cure program pathway, sharing insights and exploring challenges from a development, manufacturing, and testing perspective. Register now to join us for this free webinar sponsored by Charles River Laboratories: https://ow.ly/q9b950RlmGt #GeneTherapy James Cody Lisa Kirkwood Phil Vanek Samarendra Mohanty Victor Hernandez
-
Exciting News in Healthcare! Explore the transformative Academic Payvider model showcased in a recent study by Population Health Management. 🤝 This innovative approach bridges the gap between payers and providers, promising enhanced value-based care. Discover how Academic Payviders are revolutionizing healthcare delivery, reducing administrative burdens, and boosting patient outcomes. Don't miss out on this groundbreaking solution! Read more: https://lnkd.in/dUGE_Kbu #HealthcareInnovation #AcademicPayviders #ValueBasedCare
-
🔬 Breakthrough in MS Research! New findings in the Journal of Interferon & Cytokine Research reveal that interferon-ß (IFN-ß) significantly regulates gene expression and alternative splicing in multiple sclerosis (MS). This discovery advances our understanding of interferon genetics, gene regulation, and the role of cytokines in autoimmunity. Research by Anthony Reder and Xuan Feng from the University of Chicago Department of Medicine highlights new pathways for MS treatment strategies. Funding was provided by unrestricted grants from Bayer | Pharmaceuticals, the National MS Society, and the University of Chicago's Genomics Core facility for microarray assay support. 🔗 Read more about their impactful work: https://lnkd.in/eREWFwN9 #MultipleSclerosis #InterferonResearch #GeneRegulation #Autoimmunity #MedicalInnovation